new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)




  

Portola Pharmaceuticals Inc patents

Recent patent applications related to Portola Pharmaceuticals Inc. Portola Pharmaceuticals Inc is listed as an Agent/Assignee. Note: Portola Pharmaceuticals Inc may have other listings under different names/spellings. We're not affiliated with Portola Pharmaceuticals Inc, we're just tracking patents.

ARCHIVE: New 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "P" | Portola Pharmaceuticals Inc-related inventors




Date Portola Pharmaceuticals Inc patents (updated weekly) - BOOKMARK this page
02/16/17Cerdulatinib for treating myeloma
01/19/17Unit dose formulation of antidotes for factor xa inhibitors and methods of using the same
12/08/16Antidotes for factor xa inhibitors and methods of using the same
11/03/16Benzamides and nicotinamides as syk modulators
08/18/16Lyophilized formulations for factor xa antidote
01/14/16Cyclohexanediamine compounds and methods for their preparation
01/07/16Antidotes for factor xa inhibitors and methods of using the same
12/31/15Process for making recombinant antidote to factor xa inhibitor
12/10/15Inhibition of tissue factor pathway inhibitor with factor xa derivatives
12/10/15Nicotinamides as jak kinase modulators
11/26/15Compounds and methods for purification of serine proteases
10/22/15Inhibitors of syk and jak protein kinases
09/24/15Bicyclic dihydropyridone kinase inhibitors
09/17/15Substituted pyrimidinyl kinase inhibitors
09/10/15Bicyclic oxa-lactam kinase inhibitors
08/27/15Method for purification of recombinant factor xa derivatives
08/13/15Prevention and treatment of thrombosis in medically ill patients
04/02/15Inhibitors of protein kinases
02/26/15Antidotes for factor xa inhibitors and methods of using the same
02/05/15Benzamides and nicotinamides as syk modulators
01/22/15Unit dose formulation of antidotes for factor xa inhibitors and methods of using the same
10/30/14Selective kinase inhibitors
10/30/14Methods and formulations of treating thrombosis with betrixaban and a p-glycoprotein inhibitor
08/07/14Platelet adp receptor inhibitors
07/03/14Compounds and methods for purification of serine proteases
05/15/14Antidotes for factor xa inhibitors and methods of using the same in combination with blood coagulating agents
04/24/14Substituted picolinamide kinase inhibitors
01/30/14Inhibitors of protein kinases
12/26/131,2,4-triazine-6-carboxamide kinase inhibitors
11/28/13Oxypyrimidines as syk modulators
09/26/13Combination therapy of 4-(3-(2h-1,2,3-triazo-2-yl)phenylamino)-2-((1r,2s)-2-aminocyclohexylamino)pyrimidine-5-carboxamide and fludarabine
09/26/13Pharmaceutical compositions, dosage forms and new forms of the compound of mula (i), and methods of use thereof
09/19/13Combination therapy with 4-(3-(2h-1,2,3-triazol-2-yl)phenylamino)-2-((1r,2s)-2-aminocyclohexylamino)pyrimidine-5-carboxamide
09/12/13Combination therapy of 4-(cyclopropylamino)-2-(4-(4-(ethylsulfonyl)piperazin-1-yl)phenylamino)pyrimidine-5-carboxamide and fludarabine
09/05/13Process for making recombinant antidote to factor xa inhibitor
07/04/13Solid composition for controlled release of ionizable active agents with poor aqueous solubility at low ph and methods of use thereof
06/27/13Inhibitors of syk and jak protein kinases
06/27/13Pharmaceutical composition and dosage forms of elinogrel and methods of use thereof
05/30/13Inhibitors of jak
05/23/13Antidotes for factor xa inhibitors and methods of using the same
05/23/13Pyrazine kinase inhibitors
01/31/13Inhibitors of protein kinases
10/25/12Antidotes for factor xa inhibitors and methods of using the same
06/14/12Platelet adp receptor inhibitors
06/07/12Benzamides and nicotinamides as syk modulators
05/24/12Inhibitors of protein kinases
05/24/12[4-(6-fluoro-7-methylamino-2,4-dioxo-1,4-dihydro-2h-quinazolin-3-yl)-phenyl]-5-chloro-thiophen-2-yl-sulfonylurea salts, forms and methods related thereto
05/24/12Inhibitors of syk and jak protein kinases
05/03/12Nicotinamides as jak kinase modulators
04/26/12Inhibitors of syk and jak protein kinases
04/12/12[4-(6-halo-7-substituted-2,4-dioxo-1,4-dihydro-2h-quinazolin-3-yl)-phenyl]-5-chloro-thiophen-2-yl-sulfonylureas and forms and methods related thereto
01/12/12Intravenous and oral dosing of a direct-acting and reversible p2y12 inhibitor
09/01/11Platelet adp receptor inhibitors
04/28/11Substituted dihydroquinazolines as platelet adp receptor inhibitors
02/10/11Combination therapy with a compound acting as a platelet adp receptor inhibitor
01/20/11Unit dose formulation of antidotes for factor xa inhibitors and methods of using the same
01/13/11Inhibitors of jak
10/07/10Antidotes for factor xa inhibitors and methods of using the same
09/16/10Platelet adp receptor inhibitors
06/17/10Solid composition for controlled release of ionizable active agents with poor aqueous solubility at low ph and methods of use thereof
05/20/10Antidotes for factor xa inhibitors and methods of using the same in combination with blood coagulating agents
02/25/10Inhibitors of syk and jak protein kinases
12/24/09Inhibitors of protein kinases
12/03/09Inhibitors of protein kinases
07/23/09Potassium channel modulators and platelet procoagulant activity
Patent Packs
06/18/09[4-(6-fluoro-7-methylamino-2,4-dioxo-1,4-dihydro-2h-quinazolin-3-yl)-phenyl]-5-chloro-thiophen-2-yl-sulfonylurea salts, forms and methods related thereto
04/16/09Antidotes for factor xa inhibitors and methods of using the same
02/26/09Protein kinase inhibitors
02/19/09Intravenous and oral dosing of a direct-acting and reversible p2y12 inhibitor







ARCHIVE: New 2016 2015 2014 2013 2012 2011 2010 2009



###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Portola Pharmaceuticals Inc in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Portola Pharmaceuticals Inc with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###




';